Problem Solving: What’s the Best Approach?

June 20, 2016

Post-it note saying 'Houston, we have a problem'

Those of you in the pharmaceutical, biotech and medical device industries who encounter process and product problems on a regular basis, you likely grimace when one lands in your lap. There is a degree of dread associated with a problem solving requirement as it represents a diversion from other pressing matters and will require effort you hadn't necessarily budgeted for yourself. Indeed, effective problem solving takes time and attention; but that's generally a small investment compared to the impact and ramifications of a serious problem not solved.

So, the reality being what it is, what is the best approach to problem solving? That's a rhetorical question for sure as there's not a one-size-fits-all answer; however, one can form a foundation of problem solving skills and techniques that can be tweaked to fit the specific nature of the problem at hand.

The table below lists the step-by-step approaches used in 3 different disciplines: Six-Sigma, CAPA and Risk Management. Although terminology differs slightly, notice how very similar each discipline utilizes essentially the same problem solving approach: problem identification (Houston, we have a problem!), evaluation (how bad is the problem?), investigation (what caused the problem?), resolution (how do we fix the problem?), improve (what's the plan for fixing the problem?), and verification of the effectiveness of the implemented remediation plan (did we truly fix the problem?).

As mentioned, there is not a universally accepted problem solving approach, especially one that will guarantee the problem will be solved effectively every time. However, one could do worse by not using the industry accepted, best-practice approaches used by those who are six-sigma, CAPA and Risk Management experts.


Learn more about ProPharma's Compliance services. Contact us to get in touch with our subject matter experts for a customized presentation.

TAGS:

Project Management and a Successful Reduction in Investigations Backlog: The Beauty and the Beast

Many of us have been faced with this beast that needs taming: a regulatory agency has conducted an inspection of your facility. Their observation is that the backlog of investigations at your site is...

April 25, 2017

FDA’s Most Frequent 483 Observations for 2016: A Reflection of Industry’s Compliance

At the beginning of each year, the US FDA posts the previous year’s Form 483 observation metrics issued by each product center. Image Source: FDA I find that reviewing these metrics provides a...

January 10, 2018

FDA's Top 483 Observations for 2017: A Reflection of Industry's Compliance

At the beginning of each federal fiscal year, the US FDA posts the previous year’s Form 483 observation metrics issued by each product center. I find that reviewing these metrics provides a valuable...